Biomedical subjects
F X Brickfield
Publications and source records attributed to F X Brickfield.
Patterns of death in world leaders.
This study presents an analysis of the mortality patterns of people who become world leaders. Using information in the public domain, we identified 261 world leaders who died between 1965 and 1996. Of these, 118 died while in office, 44% violently, often by assassination. Of the 143 leaders who died after leaving office, 11% died violently. The violent deaths occurred worldwide but most frequently in the Middle East/South Asia and sub-Saharan Africa regions. The most frequent natural causes of death among world leaders were heart disease, cancer, and stroke. Mortality patterns reveal that the longevity of those leaders who died of natural causes could have been predicted by U.S. life tables. This study suggests that world leaders are neither biologically "tougher" nor more vulnerable to disease than others; however, their odds of dying violently while in office are high.
Incidence of protozoal diarrheal disease in an expatriate community in Addis Ababa.
The incidence of diarrheal disease due to Entamoeba histolytica and Giardia lamblia in the United States Embassy American population was recorded over a 25 month period. Overall case rates of 4.2/100 person-months for amoebiasis and 3.3/100 person-months for giardiasis were distinguished by wide variations based on age group and rainfall. In some circumstances, gender and prior living in Africa also correlated with disease incidence. Practitioners should look for these entities in American expatriates in Addis Ababa, especially during the dry season.
Traditional medicine in Africa.
Explore the source record for details and available documents.
Health system reform: the case for a single-payer approach.
Explore the source record for details and available documents.
Unemployment after health care reform?
Explore the source record for details and available documents.
Concerns about universal hepatitis B immunization.
Explore the source record for details and available documents.
Erythromycin in the treatment of acute bronchitis in a community practice.
To assess the efficacy of erythromycin in treating acute bronchitis, 52 adults were enrolled in a randomized trial comparing a one-week course of erythromycin with placebo. Among smokers, no difference in outcome was noted. Among nonsmokers, trends favored more rapid resolution of key symptoms in the erythromycin group, but these trends did not generally achieve statistical significance. These results suggest a trial with a larger sample size.